Wave Life Sciences (WVE) Revenue (QoQ) (2015 - 2025)
Wave Life Sciences (WVE) Revenue (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -5.19% |
| Jun 30, 2024 | 57.06% |
| Mar 31, 2024 | -56.85% |
| Dec 31, 2023 | -40.96% |
| Sep 30, 2023 | 122.63% |
| Jun 30, 2023 | 70.98% |
| Mar 31, 2023 | 943.50% |
| Dec 31, 2022 | 334.74% |
| Sep 30, 2022 | -24.00% |
| Jun 30, 2022 | -78.57% |
| Mar 31, 2022 | -0.85% |
| Dec 31, 2021 | -95.15% |
| Sep 30, 2021 | 1,212.07% |
| Dec 31, 2020 | 173.59% |
| Sep 30, 2020 | 13.97% |
| Jun 30, 2020 | -27.25% |
| Mar 31, 2020 | 73.37% |
| Dec 31, 2019 | -18.06% |
| Sep 30, 2019 | -61.60% |
| Jun 30, 2019 | 152.08% |